|Last Price$70.63||Day Change (%)-1.00%|
|Open Price$71.12||Day Change ($)-0.71|
|Day Range70.52–71.68||52-Week Range65.55–89.20|
As of Mon 9/26/2016 5:00:00 PM | USD
Walgreens Forms Alliance With Prime Therapeutics -- Update
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
The wide-moat pharmacy benefit manager is still undervalued.
Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
If Americans sweep Democrats into office, these healthcare proposals could get a shot in the arm. Here’s how they would have an impact on earnings.
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...